DA en psoriasis

Patients With Plaque Psoriasis Undergoing Biologic Therapy May Have Under-Recognized Atopic Eczema, Which Can Significantly Affect Patient Management, Systematic Review Demonstrates

Dermatology Advisor (4/2) reports "atopic eczema is potentially under recognized in patients with plaque psoriasis undergoing biologic therapy and can have a significant effect on patient management, according to results of a systematic review published in the Journal of the European Academy of Dermatology and Venereology." The "researchers found that phenotypic eczema was reported as a cutaneous adverse event (CAE) by patients with psoriasis who underwent biologic therapy." In addition, "researchers also found that biologic agents used to treat psoriasis are not as effective atopic eczema as seen in trials of ustekinumab and secukinumab exhibiting no significant improvement in patient symptoms."

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.